121 related articles for article (PubMed ID: 38592621)
1. Associations Between Inflammatory Indexes, Coagulation Indexes, and Fuhrman Grade of Clear Cell Renal Cell Carcinoma.
Zhang Y; Sun Z; Wang Z; Guo H; Liu J; Ma H
Ann Surg Oncol; 2024 Jul; 31(7):4185-4188. PubMed ID: 38592621
[No Abstract] [Full Text] [Related]
2. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
3. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of low- and high-grade clear cell renal cell carcinoma: Tumor size versus CT perfusion parameters.
Chen C; Kang Q; Xu B; Guo H; Wei Q; Wang T; Ye H; Wu X
Clin Imaging; 2017; 46():14-19. PubMed ID: 28686936
[TBL] [Abstract][Full Text] [Related]
5. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
6. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
[TBL] [Abstract][Full Text] [Related]
7. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
[TBL] [Abstract][Full Text] [Related]
8. The role of MRI texture analysis based on susceptibility-weighted imaging in predicting Fuhrman grade of clear cell renal cell carcinoma.
Sun J; Pan L; Zha T; Xing W; Chen J; Duan S
Acta Radiol; 2021 Aug; 62(8):1104-1111. PubMed ID: 32867506
[TBL] [Abstract][Full Text] [Related]
9. Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma.
Oh S; Sung DJ; Yang KS; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB
Acta Radiol; 2017 Mar; 58(3):376-384. PubMed ID: 27235451
[TBL] [Abstract][Full Text] [Related]
10. The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma.
Steffens S; Janssen M; Roos FC; Becker F; Steinestel J; Abbas M; Steinestel K; Wegener G; Siemer S; Thüroff JW; Hofmann R; Stöckle M; Schrader M; Hartmann A; Hasenfus A; Kuczyk MA; Junker K; Schrader AJ;
Hum Pathol; 2014 Dec; 45(12):2411-6. PubMed ID: 25305793
[TBL] [Abstract][Full Text] [Related]
11. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma.
Feng Z; Shen Q; Li Y; Hu Z
Cancer Imaging; 2019 Feb; 19(1):6. PubMed ID: 30728073
[TBL] [Abstract][Full Text] [Related]
12. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
[TBL] [Abstract][Full Text] [Related]
14. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
15. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.
Hong SK; Jeong CW; Park JH; Kim HS; Kwak C; Choe G; Kim HH; Lee SE
BJU Int; 2011 Feb; 107(3):409-15. PubMed ID: 20804473
[TBL] [Abstract][Full Text] [Related]
16. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
18. Computer approach to recognition of Fuhrman grade of cells in clear-cell renal cell carcinoma.
Kruk M; Osowski S; Markiewicz T; Slodkowska J; Koktysz R; Kozlowski W; Swiderski B
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):147-60. PubMed ID: 25141491
[TBL] [Abstract][Full Text] [Related]
19. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?
Millet I; Curros F; Serre I; Taourel P; Thuret R
J Urol; 2012 Nov; 188(5):1690-4. PubMed ID: 22998910
[TBL] [Abstract][Full Text] [Related]
20. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
